Divalproex Sodium
Product Images NDC 58118-0040
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 58118-0040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Clinical Solutions Wholesale, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Structure (Divalproextablets Figure 01)
Comparison Of Percentage Of Patient Separated By Study (Divalproextablets Figure 02)
% Reduction In Cps Rate Vs % Of Patients (Divalproextablets Figure 03)
% Reduction In Cps Rate Vs % Of Patients (Divalproextablets Figure 04)
Mean 4-week Migraine Rates (Divalproextablets Figure 05)
Company Logo (Divalproextablets Figure 06)
Divalproex Sodium Dr 500mg Tablet 30 Count Blister Card (Divalproextablets Figure 09)
This is a description of a pharmaceutical product, specifically Divalproex Sodium DR 500mg tablets. The product has a NDC number of 58118-0042-8 and a Mig. NOC number of 29300-0140-05, with a GTIN of 0035818004281. The lot number is SAWPLE123 B SAWPLES058. The tablets were manufactured by Unichem Pharmaceuticals and have an expiration date of September 2018. The location of production is Hasbroek Heights, W, USA, 07604, and its specifications suggest that it may be used for clinical treatment purposes.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.